Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-centre Comparative Study to Evaluate the Anti-aggression Effect and Safety of Zotepine Versus Risperidone in Aggressive Schizophrenic Patients of Acute Ward

NCT00418873 is registered in ClinicalTrials.gov with Astellas Pharma Inc as lead sponsor.

NCT NCT00418873
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00418873 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-centre Comparative Study to Evaluate the Anti-aggression Effect and Safety of Zotepine Versus Risperidone in Aggressive Schizophrenic Patients of Acute Ward
Lead sponsor
Astellas Pharma Inc
Phase
Phase 4
Overall status
Terminated
Start date
March 31, 2007
Completion date
December 31, 2009
Enrollment
39 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

schizophrenia